Graft Versus Host Disease

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

GVHD Trial in United States (Abatacept)

Recruiting
  • Graft Versus Host Disease
  • Birmingham, Alabama
  • +8 more
Mar 16, 2022

Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

Active, not recruiting
  • Sickle Cell Disease
  • Graft Versus Host Disease
  • Washington, District of Columbia
  • +6 more
Aug 4, 2021

Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)

Terminated
  • Leukemia
  • +2 more
  • Los Angeles, California
  • +12 more
May 3, 2021

GVHD, Acute GVHD, Chronic GVHD Trial in Atlanta (Autologous mesenchymal stromal cells (MSCs))

Completed
  • Graft Versus Host Disease
  • +2 more
  • Autologous mesenchymal stromal cells (MSCs)
  • Atlanta, Georgia
    Children's Healthcare of Atlanta/Emory University
Mar 2, 2021

B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, GVHD Trial in Australia,

Completed
  • B-cell Childhood Acute Lymphoblastic Leukemia
  • +5 more
  • Phoenix, Arizona
  • +49 more
Jul 24, 2019

GVHD Trial in United States (Ibrutinib)

Completed
  • Graft Versus Host Disease
  • Duarte, California
  • +9 more
Jun 14, 2019

Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Atlanta (Thymoglobulin,

Terminated
  • Acute Leukemia
  • +11 more
  • Thymoglobulin
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Mar 30, 2018

GVHD Trial in Worldwide (cyclosporine, hydroxychloroquine, prednisone)

Completed
  • Graft Versus Host Disease
  • Tucson, Arizona
  • +103 more
Feb 12, 2014